InayofuataMwongozo unaofuata
AI kwa Upungufu wa Dawa na Mali ya Duka la Dawa
Viwanda
MWONGOZO wa Viwanda
AI katika Usalama wa Dawa na Uangalizi wa Dawa
Pharmacovigilance detects, evaluates and prevents suspected harm associated with medicines.
Sikiliza mwongozo huuInaonyeshwa na AI · ~2 min
Katika ukurasa huudk 2 kusoma
Muhtasari
FDA FAERS and WHO VigiBase contain spontaneous reports; those reports and statistical signals do not establish incidence or causation.
Dive ya kina
NLP can support extraction of suspected drug-event pairs from text, as demonstrated in a clinical narrative system evaluated in the 2018 n2c2 challenge. UMC describes VigiBase as a WHO database of reported events from health workers, the public and marketing authorisation holders. UMC signal management includes detection, validation, prioritisation, assessment and communication, combining computerized data mining with manual clinical assessment. ICH E2D(R1) minimum ICSR criteria are an event or observation, a suspect/interacting product, an identifiable patient and an identifiable reporter. A report or signal is not proof of causality.
Utekelezaji wa Ulimwengu Halisi
A clinical NLP system can extract medication and adverse-event concepts and relations from narratives; one published n2c2 system was evaluated on that shared task.
MedDRA standardizes medical terms used in safety coding.
Disproportionality analysis screens report databases for drug-event reporting patterns that warrant assessment.
ICH E2D(R1) defines minimum criteria for an individual case safety report, while local rules determine reportability.
Mustakabali wa AI katika Usalama wa Dawa na Uangalizi wa Dawa
Use models as support for extracting, coding or prioritising information, with documented validation and expert assessment. This is a cautious workflow recommendation; the cited sources do not establish that fully automated safety decisions are appropriate.
Kuiweka katika vitendo
Kwa nini ni muhimu
- Muktadha na sheria. Muktadha wa tasnia huamua kama mawazo ya AI yatadumu katika mawasiliano na ukweli.
- Udhibiti wa ubora. Vikwazo vya kikoa huathiri viwango vinavyokubalika vya makosa na miundo ya uangalizi.
- Tengeneza chaguzi. Usambazaji uliofanikiwa hulinganisha uwezo wa kiufundi na mtiririko wa kazi wa mstari wa mbele.
Jihadharini na
- Mahitaji ya udhibiti yanaweza kubatilisha prototypes zenye nguvu.
- Data ya kihistoria inaweza kusimba upendeleo unaodhuru jumuiya mahususi.
- Mifumo ya urithi inaweza kuunda vikwazo vya ushirikiano na gharama zilizofichwa.
Hatua zinazofuata
- Shirikisha wataalam wa kikoa kutoka kwa uundaji wa shida hadi tathmini.
- Tengeneza njia za ukaguzi na nyaraka kabla ya kuzinduliwa.
- Thibitisha majukumu ya kufuata na usalama mapema.
- Toa kwa awamu kwa vigezo wazi vya kusimamisha na kurejesha.
Endelea Kuchunguza
Jarida halali
Pata taarifa ya kila siku ya AI
Hadithi tatu za AI zilizothibitishwa kila asubuhi ya wiki, zimetengenezwa kwa Kiingereza rahisi. Bila malipo daima, hakuna matangazo.
Barua pepe moja kila siku ya wiki. Jiondoe kwa bonyeza moja. Hatutauza au kushiriki anwani yako.
Jijaribu mwenyewe
Take the AI in Drug Safety and Pharmacovigilance quiz
Maoni ya haraka juu ya kila jibu, na cheti kinachoweza kushirikishwa na kitambulisho kinachoweza kuthibitishwa baada ya kupita kozi.
Changia elimu ya AI bila malipo. AI Understanding ni 501(c)(3) isiyo na faida — hakuna matangazo, hakuna kizuizi cha malipo, daima. Toa mchango
Maswali yanayoulizwa mara kwa mara
What is AI in Drug Safety and Pharmacovigilance?
Pharmacovigilance detects, evaluates and prevents suspected harm associated with medicines. FDA FAERS and WHO VigiBase contain spontaneous reports; those reports and statistical signals do not establish incidence or causation.
Ni nini lengo kuu la uangalizi wa dawa?
Pharmacovigilance ni sayansi ya ufuatiliaji wa dawa kwa athari mbaya na kuchukua hatua ili kuzuia madhara ya mgonjwa, haswa mara dawa zinapokuwa sokoni.
In the published n2c2 clinical NLP system, what information did the system extract from narrative notes?
The paper describes a hybrid system for extracting medication and adverse-event concepts and relations from clinical narratives, evaluated in the 2018 n2c2 shared task.
Uchanganuzi wa kutolingana hugundua nini katika hifadhidata za matukio mabaya?
Hatua zisizo na uwiano kama vile michanganyiko ya bendera ya Uwiano wa Kuripoti Uwiano wa dawa na athari ambayo hutokea mara kwa mara bila kutarajiwa, kuashiria suala la usalama linalowezekana.
What is VigiBase, according to Uppsala Monitoring Centre?
UMC identifies VigiBase as the WHO global database of reported adverse events. A report is a suspicion and does not by itself confirm causality.
MedDRA inatumika kwa nini katika mabomba ya uangalizi wa dawa?
MedDRA ni istilahi sanifu ambayo mifumo ya NLP inachora majibu kwayo, kwa hivyo kesi zinaweza kulinganishwa na kuchambuliwa mfululizo.
Endelea kujifunza
Miongozo inayohusiana
Miongozo zaidi imechaguliwa kwa mada hii